Truvada pills

Prtizker signs Youth PrEP Bill into law

SPRINGFIELD — Illinois Gov. J.B. Pritzker signed the Youth PrEP Bill into law on Wednesday. The new law allows Illinois youth 12 years old and older to obtain preventative health care services for STDs or substance use disorder without getting parental permission, including pre-exposure prophylaxis PrEP). 

The bill was sponsored by State Rep. Lamont Robinson (D-Chicago) in the House and State Sen. Robert Peters (D-Chicago) in the Senate. and supported by the AIDS Foundation of Chicago. “Young people don’t wait to have sex until they’re 18, and HIV doesn’t wait either. This legislation will help ensure young people under the age of 18 have easy access to an incredibly effective and safe HIV prevention tool,” said Jim Pickett, AFC’s Senior Director of Prevention Advocacy and Gay Men’s Health, in a statement on Wednesday.

Bill would give Illinois youth access to PrEP

SPRINGFIELD — A bill waiting for Gov. J.B. Pritzker’s signature would give Illinois teens as young as 12 access to pre-exposure prophylaxis (PrEP). NPR Illinois reported that the bill was sponsored by State Rep. Lamont Robinson Jr. (D-Chicago). It would allow youth to get access to PrEP without needing a parent’s or guardian’s permission. From NPR Illinois:
“Unfortunately, within our youth in the black and brown community, we’re seeing an increase in HIV rates, and so this bill saves lives essentially,” Robinson says. “It is a safety net.”

Truvada pills

Chicago youth survey finds PrEP use doesn’t lead to more STIs

MEXICO CITY — A survey of young gay and bisexual men and transgender women in Chicago, a portion of whom were on pre-exposure prophylaxis (PrEP), has found no direct relationship between starting PrEP and any increase in subsequent sexually transmitted infections (STIs). AIDSmap reported that the survey did find that people had more condomless sex, but it did not lead to more STIs. From AIDSmap:
Ethan Morgan of Chicago’s Northwestern University and Center for AIDS Research told the 10th International AIDS Society Conference in HIV Science (IAS 2019) is Mexico City that data were collected as part of RADAR, a cohort study of young men who have sex with men and transgender women aged between 16 and 29. 

A total of 744 young people who attended six or more study visits were followed out of a total cohort of 1100. During the study period, a third of participants started PrEP (32.9%). (The fact that this was only 21% in the pre-conference abstract submitted a few months ago shows evidence of a rapid expansion in PrEP use.) About a third were also diagnosed with a rectal STI: 17% with rectal gonorrhoea and 23% with rectal chlamydia (some with both).

Truvada pills

WHO endorses the use of event-driven PrEP

MEXICO CITY — The World Health Organization (WHO) announced its updated  recommendation for pre-exposure prophylaxis (PrEP) to include event-driven PrEP taken before and after sex – also called on-demand PrEP  – as an HIV prevention option for men who have sex with men. According to AIDSMap, the pdate was announced at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. AIDSMap reported that event-driven PrEP involves taking a double dose (two pills) of Truvada (tenofovir disoproxil fumarate/emtricitabine) between 2 and 24 hours before sex is anticipated, and then, if sex occurs, one pill 24 hours after the double dose and another 24 hours later. If sex occurs several days in a row, one pill should be taken each day, until 48 hours after the last event. In 2015, Dr Jean-Michel Molina of the University of Paris reported that event-driven PrEP reduced the risk of HIV infection by 86% among gay and bisexual men in the French Ipergay study – equalling the protective effect of daily PrEP in the UK PROUD study, the medical news website reported.